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ABSTRACT 
Biomedical researchers use of inhalational anesthetics has increased in recent years. Use of 
isoflurane as an inhalational anesthetic may result in human exposure to waste anesthetic gas. Potential 
health effects from exposure include genotoxic and hepatotoxic effects with some evidence of teratogenic 
and reproductive effects. Research suggests that exposure to waste anesthetic gas within human hospital 
settings has improved substantially but exposures to biomedical researchers and veterinarians still 
requires improvement. A number of biomedical research facilities are located at The University of 
Queensland, Australia, where researchers and animal handlers are potentially exposed to waste isoflurane 
gas. There is limited published data on the exposures received by biomedical researchers performing 
routine procedures. This project aimed to assess isoflurane exposure received during routine rodent 
anesthetic protocols performed at the university. Atmospheric concentrations of isoflurane were assessed 
via two methods – personal active gas sampling using sorbent tubes, and direct readings using infrared 
spectroscopy. Total procedure and isoflurane exposure times ranged from 135 minutes to 268 minutes. 
Personal sorbent tube sampling detected isoflurane levels from below detectable limits (<0.01░ppm) to a 
Time Weighted Average for the task (TWA-Task) of 6.20░ppm (0.73 ± 9.13). Participants were not 
exposed to isoflurane outside of the sampling period during the remainder of the workday. TWA-8░hr 
adjusted levels ranged from below the limit of detection to 1.76░ppm isoflurane (0.69░ppm ± 
0.61░ppm). The infrared spectroscopy readings taken in the breathing zone of participants ranged from 
0.1░ppm to 68░ppm. Results indicate that if adequately controlled through good room ventilation, 





































minimal. However, where industry standards are not met exposures may occur, including some high peak 
exposures. 
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The use of isoflurane and other inhalational anesthetics in biomedical research has increased in 
recent years (1). The shift towards the use of inhalation anesthesia is likely being driven by the moral and 
ethical considerations associated with the use of animals in research (2). Regardless of the increase in 
inhalation anesthetic use, there is still an increased anesthetic risk to rodents due to their small size. It is 
technically difficult to intubate rodents so therefore the majority of inhalation anesthetics are delivered via 
a facemask and relying on the animal breathing spontaneously (2). Along with risks to rodents, researchers 
and handlers can also potentially be exposed to waste anesthetic gas (WAG) (3, 4). 
Concerns over the potential for reproductive and teratogenic effects from exposure to trace levels 
of WAG have been raised since 1967 when Russian epidemiologists published the results of a health 
questionnaire from 300 hospital anesthetists (5). Although there is evidence for such health effects from 
older style halogenated anesthetics, the human evidence for isoflurane exposure is limited. Issues with 
confounding variables, retrospective study designs, and lack of quantitative measures of exposure have 
affected past research (6). Older style inhalational anesthetics are metabolized by the body to a much 
greater extent (e.g. halothane 20--50% and methoxyflurane 50%) (7-9). The risk of health effects from 
these gases is therefore greater than for isoflurane, which has a significantly lower percentage 
metabolized at 0.2% (7). Data on chronic health effects from exposure to these newer style halogenated 
anesthetics is lacking and there remains contradictions in the literature (10). 
Occupational Exposure Standards (OES) for isoflurane have been established based upon the 
effects of the older halogenated anesthetics and are outdated. Specific isoflurane OESs differ between 
countries and range from a Time Weighted Average, 8-hour (TWA-8░hr) of 2░ppm in Norway to 
50░ppm in the United Kingdom. In the United States, the Occupational Safety and Health Administration 
(OSHA) has not established a permissible exposure limit (PEL) for isoflurane but recommends that 





































Health (NIOSH) has a recommended exposure limit (REL) of 2░ppm for any halogenated anesthetic 
(without concomitant nitrous oxide) for a period of time not to exceed one hour (12). Australia does not 
currently have a specific OES for isoflurane but has a standard for enflurane (TWA-8░hr 0.5░ppm) (13). 
Enflurane is an isomer of isoflurane having the same molecular formulae and similar toxicity(14). It is 
therefore reasonable to apply this OES in an Australian setting. 
There have been considerable improvements over time in the methods for controlling workers’ 
exposure to trace WAG, particularly within human hospital environments. However, the control measures 
required for human surgery are not always possible within a biomedical research setting and the literature 
suggests that exposure to WAG is highest within research and veterinary settings (3, 4). 
A number of biomedical research facilities are located at The University of Queensland (UQ), 
Australia, potentially exposing researchers and animal handlers to waste isoflurane gas. Like any 
potentially hazardous chemical exposure, it is important levels are kept to as low as reasonably 
practicable. This project aimed to collect data on the levels of isoflurane exposure within UQ’s laboratory 
animal research facilities. Personal sorbent tube sampling combined with direct readings from infrared 
spectroscopy were performed during routine research anesthetic protocols to evaluate isoflurane exposure 
of researchers and laboratory animal technicians. 
MATERIALS AND METHODS 
Ethics Approval 
Human ethics approval was granted by the UQ Ethics Committee (UQ Institutional Human 
Research Approval Number: 2013001289), in conjunction with approved UQ Animal Ethics (UQ Animal 
Ethics Committee Approval Number: UQBR/QBI/143/13/T). 
Recruitment of study participants 
Study participants were volunteers recruited from amongst the University’s research higher 





































research facilities and were personally administering isoflurane inhalational anesthesia to rodents. Staff 
and students potentially working with isoflurane were invited to participate in the study. Five female 
research higher degree students currently using isoflurane for their research projects volunteered to be 
involved. 
Rodent Procedures examined 
A total of six data sets were collected from participants performing isoflurane anesthetic procedures on 
laboratory rodents. One participant was monitored twice on separate occasions to investigate an issue 
with the room’s ventilation system. Data sets 1 and 5 involved a non-invasive ultrasound imaging 
procedure requiring 15--20 minutes of immobilization per rat. In data sets 2 and 4, data was collected 
from rats undergoing minor surgical intervention with each individual procedure taking no more than ten 
minutes per rat. Data sets 3 and 6 involved up to 1.5 hours per rat for major surgical intervention. The 
major surgical intervention differed between data sets 3 and 6, with data set 3 involving femoral artery 
cannulation, while data set 6 involved cranial osteotomy for intracranial injection. Facility set-up, control 
measures and anesthetic procedures differed for each data set, refer to the Facility Set-Up and Discussion 
sections for further details. 
Facility Set-up 
Facility type and room ventilation parameters were recorded for each workstation. Facility type 
was recorded as research or laboratory. A research facility was defined as an anesthetic workstation 
located within a vivarium. A laboratory was defined as a workspace provided to researchers outside a 
vivarium. The number of room air changes per hour and the percentage fresh air per room air change 
were recorded for each facility. Data is tabulated in Table 1. All set-ups utilized active gas scavenging 
systems. 
An induction chamber was used for initial anesthetic induction of rodents with the exception of 





































in a purpose-built red tinted 6░mm acrylic-sheeting box (25  35  15░cm) with a 6.4░mm oxygen inlet 
and a 22░mm scavenger outlet fitting attached to the lid. The induction chamber for data set 4 was also a 
purpose-built acrylic box (cm) built with 8░mm acrylic sheeting fitted with a 6.4░mm oxygen inlet and a 
22░mm scavenger outlet fitting on either sides of the container. Data set 2 utilized a modified 
commercially available plastic container (22  15  11░cm) as the induction chamber. Two holes were 
made on either side of the chamber to allow for an inlet hose and outlet hose to be fitted and held in place 
using adhesive tape. 
Data sets 1, 3 and 5 were recorded from rats maintained on a Darvall non-rebreathing circuit and 
ZDS mask (Advanced Anesthesia Specialists, Gladesville, NSW Australia). A Vetquip rodent circuit with 
a size 0 mask VQ3315 (Vetquip, Castle Hill, NSW Australia) was used for data set 4 and data set 2 
utilized a SDR rodent mask with 7/16 diaphragm (SDR Clinical Technology, Middle Cove, NSW 
Australia). 
Isoflurane gas sampling and analysis 
Atmospheric concentrations of isoflurane were assessed via two methods, personal active gas 
sampling (to collect time weighted average samples) using sorbent tubes, and grab sampling to collect 
real-time measurements using a direct reading instrument. 
The personal active gas sampling (using sorbent tubes) was completed in accordance with the 
Australian Standard method, AS 2986.1:2003 Workplace air quality-Sampling and analysis of volatile 
organic compounds by solvent desorption/gas chromatography and specifically validated Occupational 
Safety and Health Administration (OSHA) sampling method number 103 for Enflurane, Halothane and 
Isoflurane (16). Sampling was completed using SKC AirChek XR5000 sampling pumps (SKC, Inc., PA) 
fitted with low flow adaptor and low flow tube holder. The two sampling pumps used were within their 
12-month calibration period. The samples were collected by drawing a known volume of air through SKC 





































personal sampling. The sampling pumps were calibrated before and after sampling using a Defender 510 
Low Flow DryCaL calibrator (MesaLabs, Inc. CO). Post calibration flow rates were all within +/- 5% of 
pre-sampling flow rates. Two field blanks were prepared and analyzed for each set of personal air 
samples. The tube holder was clipped within the breathing zone (300░mm spherical region surrounding 
the mouth and nose) of each participant so that it remained in a vertical position for the duration of 
sampling. Sampling was performed for the full duration of the rodent procedure. Data was collected from 
procedures of no less than 2-hours total duration, as required by the OSHA sampling method. Sample 
tubes were capped and sealed immediately following sampling and were stored in a refrigerator until 
being transported on ice via express courier to the laboratory for analysis. Samples were collected during 
typical, routine procedures performed over a three month period. Samples were analysed by TestSafe 
Australia – Chemical Analysis Branch (WorkCover New South Wales, Australia), a laboratory accredited 
with the National Association of Testing Authorities, Australia (NATA) to AS ISO/IEC 17025:2005 (17). 
Sampling tubes were desorbed with CS2 and analysed via Gas Chromatography (GC) with Flame-
Ionization Detector (FID). Isoflurane concentration, oxygen flow rate and WAG scavenging equipment 
were recorded for each sampling period. General room dilution ventilation including air changes per hour 
were recorded for each anesthetic location. 
The MIRAN 205B Series SapphIRe-XL Infrared Spectrophotometer (Thermo Electron 
Corporation, Franklin, MA) was used for grab sampling and recorded direct isoflurane levels. The 
detection limit of the MIRAN is 0.5░ppm with an accuracy of +/- 10% at the 11.372 micron wavelength 
and a 100░ppm high range limit. 
MIRAN readings were completed in accordance with the Manufacturer’s instructions. Before and after 
each data collection period, an in-field zero calibration check of the instrument was performed. The direct 





































details. A sampling wand attached to the MIRAN was placed in the various sampling positions and 
readings recorded. The MIRAN has a response time for a single wave length of 20 seconds. 
Direct readings were collected from the participant’s breathing zone and surroundings (e.g. 
directly above the rodent facemask, anesthetic tubing connection points, and exhaust scavenging points) 
to investigate potential sources of exposure (e.g. WAG leakage from the anesthetic system). Intermittent 
MIRAN recordings were performed depending on tasks involved with each procedure to investigate 
potential peak exposures, including during rodent manipulation periods (i.e. rodent movement from the 
induction chamber and placement onto a facemask). Samples were recorded as close as possible within 
the breathing zone of each participant and at a similar proximity to the sorbent tube. The direct reading 
time was recorded along with the peak reading. 
Raw data from both the personal sorbent tube sampling and the MIRAN direct readings were 
collated and tabulated. Personal sorbent tube sampling data was displayed as TWA-Task (being the time 
weighted average result for the period of the rodent procedure) and also as an adjusted TWA-8░hr for 
comparison with Occupational Exposure Standards, based on nil exposure outside the sampling period. 
All data is presented in mean ± standard deviation (for normally distributed data) or geometric mean ± 
geometric standard deviation (for log normally distributed data). 
Isoflurane sorbent sampling tube results were provided by TestSafe Australia as a weight of 
isoflurane detected (μg). The TWA Concentration was calculated with the formula: TWA concentration = 
isoflurane mass / volume of air collected. Two field blanks were prepared and analyzed for each set of 
samples. All field blanks returned no detectable levels of isoflurane. 
The calculated TWA-Task concentration (mg/m3) was converted to a TWA-Task (ppm) using the 
formula: 
TWA-Task in ppm = (TWA-Task in mg/m3 x 24.45)/gram molecular weight of isoflurane at 1 atmosphere 





































Based on nil exposure outside the sampling period (determined via questioning of each 
participant), the TWA-Task concentration was converted to a TWA-8░hr concentration in ppm for 
comparison with 8-hour occupational exposure standards. Results from the direct reading instrument 
(ppm readings) and from the personal sampling (TWA-8░hr and TWA-Task) were entered into the 
American Industrial Hygiene Association (AIHA) software IHSTAT v2.29, for statistical analysis. 
MIRAN results were entered into the software separately for each person and descriptive statistics 
calculated. All sets of MIRAN direct reading instrument results and the TWA-Task results were log 
normally distributed, so non-parametric statistics were examined (geometric mean ± geometric standard 
deviation). The 8-hour adjusted personal sampling results (TWA-8░hr) were normally distributed, 
therefore parametric descriptive statistics were calculated (mean ± standard deviation). 
RESULTS 
Procedure times (isoflurane exposure) ranged from 135 minutes to 268 minutes. Personal sorbent 
tube sampling detected isoflurane levels from below detectable limits to a TWA-Task of 6.20░ppm (0.73 
± 9.13) (Table 1). Participants were not exposed to isoflurane outside of the sampling period during the 
remainder of the workday. Adjusted TWA-8░hr levels ranged from not detectable, to 1.76░ppm 
isoflurane (0.69░ppm ± 0.61░ppm) (Table 1). Direct reading MIRAN results collected from within the 
breathing zone are summarized in Table 2 and are presented graphically in Figures 1 to 6. The geometric 
mean ± geometric standard deviation for the MIRAN direct reading results obtained from the six 
participants ranged from 0.6░ppm ± 1.5░ppm (data set 4) to 6.8░ppm ± 1.3░ppm (data set 6). Peaks 
observed in the MIRAN direct readings mainly correspond with opening of the induction chamber to 
place or remove the rodent (refer data sets and Figures 1, 2, 3, and 5). Higher MIRAN direct reading 
results were also observed during performance of procedures requiring the researcher to work with their 






































The aim of the research was to carry out an evaluation of exposures to waste isoflurane gas 
received during animal research procedures within the university’s facilities. Although the literature on 
human health effects from chronic exposure to specifically isoflurane is limited, there is still a potential 
health risk posed by long-term exposure to low levels of the gas. Thus, it was important to investigate 
exposures and to assess the potential risk by comparing levels observed with occupational exposure 
standards. Of the six personal samples, three resulted in TWA-8░hr exposures that were higher than the 
Australian OES for enflurane of 0.5░ppm but all were below isoflurane-specific international OESs for 
isoflurane, which range from 2░ppm to 50░ppm (2░ppm in Norway (18), 10░ppm in Finland and Sweden 
(19, 20) and 50░ppm in Spain, Ireland and the United Kingdom (21-23)). 
The concentrations found are comparable to published data. A recent study carried out in the 
United States (24) reported a mean TWA-8░hr of 0.62 ± 0.47░ppm (range 0.04 – 1.64░ppm) for 
pharmaceutical laboratories, which closely aligns with the mean TWA-8░hr of 0.69░ppm ± 0.61░ppm 
(range <0.01 – 1.76░ppm) for biomedical facilities in this study. The MIRAN direct reading levels also 
compare with other published data (3, 4, 25, 26). 
The study identified a number of work practices and environmental workplace conditions that 
contributed to incidences of peak exposures. 
 Peak isoflurane levels were observed during anaesthetic induction and in particular during rodent 
manipulation (i.e. when induction chambers were opened to remove the anaesthetised rodent and 
place onto the facemask). 
 Poorly fitted rodent facemasks permitted leakage of waste gas into the room atmosphere and often 
directly into the breathing zone of the researcher. In data set 2, a poorly fitted rodent facemask was 
used and in addition, the researcher’s breathing zone was in close proximity to the mask during each 
procedure (average 8--10 minutes per rat for 10 rats). In data set 6, a latex glove was retrofitted into 





































 Higher levels of WAG were recorded due to issues with the room general dilution ventilation 
system. In data sets 1 and 3, blocked air filters were found within the surgery room’s air handling 
unit. 
 The placement of local exhaust ventilation hoods (LEV hood) contributed to the overall WAG 
exposure. In several cases the LEV hood opening was not well positioned to assist with drawing 
WAG away from the breathing zone (data sets 1, 3, 5 and 6). In comparison, data set 4 utilised a 
wall mounted exhaust hood, which effectively drew WAG away from the breathing zone. In 
addition, the anaesthetic scavenging hose was positioned inside the extraction hood to produce an 
active anaesthetic scavenging system. These two systems in combination produced a non-detectable 
level of isoflurane for data set 4. 
 Custom induction chambers leaked WAG. Poor seals in custom chambers were the likely cause of 
the WAG leakage into the room atmosphere from data sets 2 and 6. 
RECOMMENDATIONS 
Based on these observations, on recommended practices and on the results obtained from both the 
personal and MIRAN direct reading results, several key control measures are recommended to reduce 
WAG exposure to as low as reasonably achievable. These include: 
 Use of active gas scavenging systems 
 Use of commercially constructed induction chambers with good seals and correct positioning of 
chambers under a LEV system designed to capture fugitive emissions and reduce peak exposures 
when opening 
 Use of well-designed and correctly positioned local exhaust ventilation (LEV) hoods 
 Sufficient numbers of air changes per hour of 100% fresh air (27 air changes per hour was 





































 Ensuring rodent facemasks provide a good seal around the rodent’s face and neck and/ or ensure 
adequate capture from active gas scavenging systems (e.g. LEV) 
 Documented systems to ensure air filters within air handling units are well maintained 
 Safe work procedures combined with training in the safe use of isoflurane. 
Gas Scavenging 
Since the early reports in the 1960░s (5) and 1970░s (27-29) of the potential for inhalational 
anaesthetics to cause reproductive and teratogenic effects, government bodies, particularly NIOSH (30) and 
OSHA (11) in the USA, have provided guidance on the control of anaesthetic gases in human operating 
theatres. The key control measure has been the use of either an active or passive gas scavenging system 
on the anaesthetic machine. One study showed that commercially available charcoal canisters used for 
passive scavenging in animal procedures, produced significant variations in isoflurane emissions from the 
activated charcoal canisters, with some canisters emitting isoflurane levels exceeding the American 1-
hour ceiling concentration of 2░ppm as recommended by NIOSH (31). The study recommended the use of 
passive WAG scavenging in conjunction with an active scavenging system. 
Since the introduction of scavenging systems there has been no published epidemiological data 
demonstrating adverse effects on operating room personnel where scavenging systems are in place (32). It 
is therefore vital that scavenging systems, particularly active systems, continue to be used at the 
University and other animal research facilities. It is also important that these systems be well maintained. 
Active gas scavenging and local exhaust ventilation (LEV) 
Findings from this study illustrate that it is possible to reduce WAG exposures to below the limits 
of detection when good ventilation is in place, including the use of active gas scavenging techniques such 
as LEV. The location of the LEV hood or opening is important to ensure that WAG is being drawn from 
the source toward the hood and away from the breathing zone of the researcher. Induction chambers 





































exposures when opening. Recent published research has shown the importance of active gas scavenging 
using a LEV system with a reduction in WAG levels by a maximum of 96% and mean of 85% when LEV 
was used in comparison to passive gas scavenging alone (33). It is recommended that LEV systems be used 
to control WAG exposures within University research facilities. Maintenance and testing of these systems 
is also vital to ensure their ongoing effectiveness. 
General Room Ventilation 
General room ventilation is important to remove any waste isoflurane gas present in the 
atmosphere of the room. The American Institute of Architects released guidelines in 1992 for hospitals 
and medical facilities, which established recommendations for room ventilation in operating rooms of 15 
to 21 air exchanges per hour, of which three must be fresh outside air and in post anaesthesia rooms, six 
air exchanges per hour, two of which must be fresh outdoor air (30). In Australia, air exchange rates for 
health care settings, including operating rooms are established within AS 1668.2-2012: The use of 
ventilation and air-conditioning in buildings, Part 2: Mechanical ventilation in buildings (34). The 
Standard requires an air exchange rate of 20 air changes per hour in operating rooms and the minimum 
outdoor airflow rate of, which ever is the greatest of 20░L/s per person at an occupancy of 5m2 per 
person, or 10 air changes per hour of fresh air. Supply air must be filtered using high efficiency 
particulate air (HEPA) filters in accordance with AS 4260:1997 High efficiency particulate air (HEPA) – 
Classification, construction and performance (35). 
In Australia, general requirements for the provision of adequate room ventilation for laboratories 
is provided in AS/NZS 2243.1:2005: Safety in laboratories – Planning and operational aspects (36). There 
are also specific requirements for ventilation of laboratories with animal containment facilities in AS/NZS 
2243.3:2010 Safety in laboratories, Part 3 Microbiological safety and containment (37), which are 
designed to control microbiological hazards. These requirements are specific to the levels of protection 





































provided was excellent (27 air changes/hour of 100% fresh air) and assisted to minimise levels to below 
limits of detection and therefore below the OES, providing an excellent level of control. 
Rodent facemasks 
The degree to which a tight fit can be achieved between a rodent’s face and the facemask 
delivering anaesthetic gas is an important factor in reducing levels of WAG in the atmosphere of the 
operating room or laboratory. In this study, when the fit did not provide a tight seal, isoflurane levels 
measured in the breathing zone ranged from 5░ppm to 8.1░ppm (data set 6). When a tight seal was 
achieved, the levels were much lower at approximately 0.3░ppm. A similar finding was observed in a 
published study investigating the seal of rodent facemasks and the effects on isoflurane levels (38). The 
authors concluded that their data suggests – 
“that researchers working with standard rodent non-rebreathing circuits equipped with 
conventional conical facemasks will be regularly exposed to waste isoflurane flowing through the 
face/port interface. Transient contact will likely occur at levels exceeding 50░ppm …” (38). 
It is recommended that isoflurane users investigate the best type of facemask to provide a tight seal 
between the face and delivery system and to accommodate the needs of the procedure and disinfection 
requirements. 
CONCLUSION 
Findings from this study indicate that the levels of exposure to WAG experienced during 
experimental rodent procedures within this University setting, are low but typically, and not unexpected, 
peaks occur during rodent manipulation such as opening and removal from induction chambers. It is 
recommended that induction chambers be located under correctly positioned local exhaust ventilation. 
Results from data set 4 illustrate that where laboratory practices are at industry standards, 
including the use of effective active gas scavenging systems, it is possible to reduce waste isoflurane gas 





































required to ensure that all exposures are reduced to as low as reasonably practicable by adopting the 
recommended control measures consistently across all University facilities. Documented procedures 
combined with training for users is required to ensure that WAG exposures are being managed in 
accordance with best practice throughout the University. 
Further research is required to provide more definitive information on the potential for adverse 
health effects from chronic exposure to waste anaesthetic gases such as those observed in this study. In 
particular, prospective epidemiological research is required on occupationally exposed groups. 
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1 Research Rats 20
a 100% Chamber 268 1.77 0.99 
2 Laboratory Rats 14 20% Chamber 135 1.45 0.41 
3 Research Rats 20
a 100% Chamber 260 0.78 0.42 
4 Research Rats 27 100% Facemask 224 <0.01
b
 <0.01b 
5 Research Rodents 20 100% Chamber 216 1.17 0.53 
6 Laboratory Rats unknown unknown Chamber 136 6.20 1.76 
aBlocked filters in air conditioning system at time of sampling 





































TABLE 2. Summary of MIRAN direct readings combined with personal sampling results 
MIRAN Direct Reading Results Collected in Breathing Zone 
























1 27 0.8 – 66.9 4.5 3.6 1.77 0.99 
2 44 4 – 68.0 14 2.0 1.45 0.41 
3 31 0.1 – 54.0 2.5 4.7 0.78 0.42 
4 8 0.3 – 1.0 0.6 1.5 <0.01b <0.01b 
5 13 0.7 – 29.9 3.4 3.2 1.17 0.53 
6 12 3.8 – 11.5 6.8 1.3 6.20 1.76 
a Number of direct reading samples taken in breathing zone depended in duration of procedure and 
tasks undertaken during procedure 














































































































































































































































































































































Activity performed by study participant 
Date Set 1 - WAG MIRAN Direct Reading Results (ppm) and Activity 

































































Activity performed by study participant 
Date Set 2 - WAG MIRAN Direct Reading Results (ppm) and Activity 









































































































































































































































































































































































































Activity performed by study participant 
Date Set 3 - WAG MIRAN Direct Reading Results (ppm) and Activity 














































































Activity performed by study participant 
Date Set 4 - WAG MIRAN Direct Reading Results (ppm) and Activity 
































































Activity performed by study participant 
Date Set 5 - WAG MIRAN Direct Reading Results (ppm) and Activity 

































































Activity performed by study participant 
Date Set 6 - WAG MIRAN Direct Reading Results (ppm) and Activity 
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